Using MRI-guided radiation, Providence radiation oncologists can precisely target tumors for destruction while minimizing damage to surrounding normal tissue.
For third year in a row, Providence St. Vincent Medical Center has received America’s 50 Best Hospitals Award. This recognition places Providence among the top 1% of the country's hospital
A new clinical trial offered at Providence Cancer Institute to study the safety and effectiveness of two different treatments for people under age 70 with previously untreated non-GCB DLBCL.
Providence Cancer Institute highlights a year of engaging with and supporting our patients, partner organizations and community.
Many emergency rooms, clinics and urgent care centers are experiencing a sharp rise in the number of cases of RSV, flu and COVID.
Providence Cancer Institute is offering a phase III trial for patients with gynecologic cancers and two early phase trials that will study new medications in treating solid tumors.
The Providence Center for Weight Management's bariatric surgery program has been recognized for high-quality distinctions from Healthgrades.
Providence is seeing many children with RSV. Under guidance from OHA, we have activated crisis standards of care in pediatric units at Providence Portland Medical Center.
Providence currently accepting applications for an Immuno-Oncology Research Fellowship being offered through Earle A. Chiles Research Institute.
Bernard A. Fox, Ph.D., leader of the Laboratory of Molecular and Tumor Immunology honored by the Society for Immunotherapy of Cancer for legacy of public service.
A joint statement from Kaiser Permanente, Legacy Health, OHSU Health and Providence